3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
113
INDUSTRY
61
NIH
5
OTHER_GOV
4
NETWORK
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Breast
3
Conditions
Breast Neoplasms
3
Stomach Neoplasms
1
Rectal Neoplasms
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Elderly Metastatic Breast Cancer Population
1
Colonic Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
39
Docetaxel
30
Tamoxifen
29
Paclitaxel
27
Doxorubicin
26
Trastuzumab
20
Radiotherapy
18
Epirubicin
16
Letrozole
13
exemestane
11
Fluorouracil
11
Anastrozole
11
Capecitabine
10
Bevacizumab
10
Immunohistochemistry
9
Filgrastim
9
Fulvestrant
8
Methotrexate
7
Gene Expression Profiling
7
palbociclib
6
Zoledronic Acid
6
Microarray Analysis
6
Lapatinib
6
Goserelin
6
Chemotherapy, Adjuvant
6
Amplified Fragment Length Polymorphism Analysis
6
Vinorelbine
5
Triptorelin Pamoate
5
Carboplatin
5
Absorptiometry, Photon
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Neoplasms
×
pertuzumab
×
Clear all
NCT03644186
2024-12-13
TOUCH
ETOP IBCSG Partners Foundation
Phase 2
Completed
147 enrolled
11 charts
NCT03412643
2023-03-06
FB-12
NSABP Foundation Inc
Phase 2
Unknown
64 enrolled
NCT01850628
2021-10-05
NSABP Biospecimen Discovery Project
NSABP Foundation Inc
Unknown
50 enrolled